The European Respiratory Society congress (ERS) was held on 7–9 September 2020 and delivered the latest innovations in respiratory medicine to over 33,000 delegates.

myPOCacademy hosted a virtual symposium covering CRP point-of-care testing in the time of COVID-19 and for the reduction of antibiotic prescribing in acutely exacerbated COPD patients, watched live by nearly 500 healthcare professionals.

Hear expert perspectives on the value of C-reactive protein (CRP) point-of-care testing (POCT) in the context of COVID-19 by watching the on-demand symposium recording which is now available exclusively on myPOCacademy.

Featuring expert opinion from front-line healthcare staff from around the world, discussions centered around the following topics:

• CRP level as an inflammatory marker for severity and risk assessment in COVID-19
• CRP POCT for identification of patients at high risk of severe outcomes in COVID-19
• CRP POCT for optimal allocation of hospital and intensive care unit resources
• CRP POCT to aid clinical decision-making and guide antibiotic prescribing in patients presenting with symptoms of respiratory tract infections
• The role of CRP POCT in the fight against anti-microbial resistance
• CRP POCT as a diagnostic strategy in patients presenting with acute exacerbation of chronic obstructive pulmonary disease (COPD) in primary care (the PACE study)

Click here to watch the ERS symposium recording in full.